C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Invests $691,000 in The Cooper Companies, Inc. (NASDAQ:COO)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The fund bought 6,970 shares of the medical device company's stock, valued at approximately $691,000.

Other hedge funds also recently made changes to their positions in the company. Fulton Bank N.A. grew its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock worth $342,000 after purchasing an additional 109 shares in the last quarter. Mitchell & Pahl Private Wealth LLC boosted its stake in Cooper Companies by 1.5% in the third quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company's stock worth $881,000 after buying an additional 117 shares in the last quarter. Bleakley Financial Group LLC boosted its stake in Cooper Companies by 2.1% in the third quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company's stock worth $636,000 after buying an additional 119 shares in the last quarter. Mather Group LLC. lifted its position in Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock valued at $177,000 after purchasing an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB lifted its position in Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after purchasing an additional 136 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on COO shares. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a "buy" rating for the company in a report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Morgan Stanley decreased their price objective on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, December 6th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Friday, December 6th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, Cooper Companies currently has a consensus rating of "Moderate Buy" and a consensus price target of $117.00.

Cooper Companies Stock Performance

Shares of Cooper Companies stock traded down $5.58 during trading on Monday, hitting $88.10. 3,052,861 shares of the company's stock traded hands, compared to its average volume of 1,320,943. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The stock has a market capitalization of $17.58 billion, a P/E ratio of 45.18, a PEG ratio of 2.41 and a beta of 1.00. The business has a 50-day simple moving average of $93.72 and a 200-day simple moving average of $99.78.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business's revenue for the quarter was up 9.8% on a year-over-year basis. During the same period last year, the firm posted $0.87 earnings per share. As a group, analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.